<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>MedTech on FinanClub</title>
    <link>https://finan.club/tags/medtech/</link>
    <description>Recent content in MedTech on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 24 Jan 2024 09:08:15 +0000</lastBuildDate><atom:link href="https://finan.club/tags/medtech/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Wed, 24 Jan 2024 09:08:15 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:51
Chances: Johnson &amp;amp; Johnson beat fourth-quarter expectations with strong performance in the medtech segment. The company reported adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus. Sales increased by 7.3% year-over-year to $21.4 billion, surpassing the consensus. Risks: Johnson &amp;amp; Johnson&amp;rsquo;s stock tumbled after the company reported lower profit margins in the medical device and technology unit last quarter.</description>
    </item>
    
  </channel>
</rss>
